- Home
- OLMA vs EAD Comparison
OLMA vs EAD Comparison
Compare OLMA & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- EAD
- Stock Information
- Founded
- OLMA 2006
- EAD 2003
- Country
- OLMA United States
- EAD United States
- Employees
- OLMA N/A
- EAD N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- OLMA Health Care
- EAD Finance
- Exchange
- OLMA Nasdaq
- EAD Nasdaq
- Market Cap
- OLMA 378.9M
- EAD 419.0M
- IPO Year
- OLMA 2020
- EAD N/A
- Fundamental
- Price
- OLMA $7.75
- EAD $7.08
- Analyst Decision
- OLMA Strong Buy
- EAD
- Analyst Count
- OLMA 5
- EAD 0
- Target Price
- OLMA $24.00
- EAD N/A
- AVG Volume (30 Days)
- OLMA 1.1M
- EAD 178.9K
- Earning Date
- OLMA 11-11-2025
- EAD 01-01-0001
- Dividend Yield
- OLMA N/A
- EAD 8.91%
- EPS Growth
- OLMA N/A
- EAD N/A
- EPS
- OLMA N/A
- EAD N/A
- Revenue
- OLMA N/A
- EAD N/A
- Revenue This Year
- OLMA N/A
- EAD N/A
- Revenue Next Year
- OLMA N/A
- EAD N/A
- P/E Ratio
- OLMA N/A
- EAD N/A
- Revenue Growth
- OLMA N/A
- EAD N/A
- 52 Week Low
- OLMA $2.86
- EAD $5.69
- 52 Week High
- OLMA $13.93
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- OLMA 64.67
- EAD 49.17
- Support Level
- OLMA $7.49
- EAD $7.07
- Resistance Level
- OLMA $8.40
- EAD $7.12
- Average True Range (ATR)
- OLMA 0.67
- EAD 0.03
- MACD
- OLMA 0.08
- EAD -0.01
- Stochastic Oscillator
- OLMA 75.63
- EAD 22.22
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.